Medicina de Família
[Preprint] “Long Covid”: sintomas persistentes após infecção por SARS-CoV-2 em uma amostra aleatória de 508.707 pessoas da comunidade.
13 Jul, 2021 | 11:27hComentário: Study explores the prevalence of long COVID in England – News Medical
Debate Pró-Con | Deveríamos postergar a vacinação contra Covid-19 em crianças?
13 Jul, 2021 | 11:25hShould we delay covid-19 vaccination in children? – The BMJ
Comunicado de imprensa: Should we delay COVID-19 vaccination in children? – British Medical Journal
Comentário no Twitter
Covid-19 vaccines in adults have been remarkably effective. There is good reason to expect that the same will be true in children.
A group of authors discuss the pros and cons of vaccinating children against covid-19 https://t.co/TOEI67YPeH
— The BMJ (@bmj_latest) July 9, 2021
Podcast | Uso de antibióticos.
13 Jul, 2021 | 11:16h#284 An Antibiotics Primer, with @IDdocAdi – The Curbsiders
M-A | Prevalência global da constipação funcional de acordo com os critérios de Roma.
13 Jul, 2021 | 11:06h
Comentário no Twitter
New research – Barberio et al – Global prevalence of functional constipation according to the Rome criteria: a systematic review and meta-analysishttps://t.co/pqkXltWnYU#constipation #gitwitter @bribarberio @DrCJudge @EdoardoSavarino @alex_ford12399 pic.twitter.com/NUnZgaVS46
— The Lancet Gastroenterology & Hepatology (@LancetGastroHep) June 4, 2021
Monitoramento domiciliar da pressão arterial: orientação para pacientes canadenses.
13 Jul, 2021 | 11:05h[Preprint] Estudo confirma o risco extremamente baixo de morte por Covid-19 em crianças – “99,995% das crianças e jovens com teste positivo para SARS-CoV-2 sobreviveram.”
12 Jul, 2021 | 11:39hComentários: Risks of severe illness in children from COVID-19 shown to be very low in largest study yet – University of Liverpool E Covid: Children’s extremely low risk confirmed by study – BBC
Estudo relacionado feito pelo mesmo grupo (preprint): Risk factors for intensive care admission and death amongst children and young people admitted to hospital with COVID-19 and PIMS-TS in England during the first pandemic year – medRxiv
Nova orientação do CDC para a prevenção da COVID-19 em escolas de educação infantil afirma que a prioridade é o retorno seguro ao ensino presencial.
12 Jul, 2021 | 11:38hComentários: Updated CDC schools guidance prioritizes in-person learning, even if all Covid-19 safety measures aren’t in place – CNN E The C.D.C. Issues New School Guidance, With Emphasis on Full Reopening – The New York Times E New CDC guidance says fully vaccinated teachers and students don’t need to wear masks indoors – CNBC E CDC calls for reopening schools fully, recommends masking – CIDRAP
Relacionado: COVID and schools: the evidence for reopening safely – Nature
Estudo randomizado | Outro estudo mostra que a azitromicina não melhora os desfechos em pacientes com Covid-19.
12 Jul, 2021 | 11:37hComentários: Trial shows that the antibiotic azithromycin does not prevent mild COVID cases progressing to hospitalization, death – European Society of Clinical Microbiology and Infectious Diseases E Azithromycin: can its benefit be ruled out in mild COVID-19? – The Lancet Respiratory Medicine
Relacionado: M-A: Azithromycin does not reduce the need for invasive mechanical ventilation or mortality in patients with Covid-19. E RCT: Azithromycin provides no benefit for community treatment of patients with suspected COVID-19 E RECOVERY trial: Azithromycin not beneficial for patients admitted to hospital with COVID-19 E E Coalition Covid-19 Brazil – Randomized trial: Azithromycin not beneficial for patients admitted to the hospital with severe Covid-19 E Coalition Covid-19 Brazil – Randomized trial: hydroxychloroquine with or without azithromycin in mild-to-moderate Covid-19
Comentário no Twitter
In patients with mild-to-mod #COVID19 managed without hospital admission, azithromycin + SOC did not reduce the risk of subsequent hospital admission or death
Read the ATOMIC2 trial here https://t.co/QXJ7T08JZS, being presented at #ECCMID2021 by lead author Tim Hinks @HinksLab pic.twitter.com/ZDiPhuQqFB
— The Lancet Respiratory Medicine (@LancetRespirMed) July 9, 2021
Pfizer afirma que é hora de um reforço (terceira dose) na vacina contra a Covid; FDA e CDC dizem que ainda não.
12 Jul, 2021 | 11:35hPfizer says it’s time for a Covid booster; FDA and CDC say not so fast – CNN
Ver também: CDC, FDA contradict Pfizer on COVID-19 vaccine booster – CIDRAP E Do I need a COVID-19 booster shot? 6 questions answered on how to stay protected – The Conversation E Pfizer suggests booster shots will be needed this year, but government officials say science will dictate the timing – The Washington Post E Pfizer to seek OK for 3rd vaccine dose; shots still protect – Associated Press E Citing the Delta Variant, Pfizer Will Pursue Booster Shots and a New Vaccine – The New York Times (poucos artigos gratuitos por mês) E Question open on need for COVID booster shot, data awaited, WHO says – Reuters
Há necessidade urgente de um correlato de proteção para as vacinas contra o SARS-CoV-2 – “Estudos recentes sugerem que os anticorpos neutralizantes podem servir como um correlato de proteção para as vacinas contra o SARS-CoV-2 em humanos.”
12 Jul, 2021 | 11:31hA correlate of protection for SARS-CoV-2 vaccines is urgently needed – Nature Medicine
Relacionado: Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection.